iCAD, Inc. (ICAD)

1.4700 -0.0200 (-1.34%) At close: 04:00PM EDT

iCAD, Inc.

98 Spit Brook Road
Suite 100
Nashua, NH 03062
United States
603 882 5200
https://www.icadmed.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 67

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Dana R. Brown	President, CEO & Executive Chair	327.95k	N/A	1965
Mr. Eric Lonnqvist	Chief Financial Officer	302.6k	N/A	N/A
Mr. Jonathan Go	Chief Technology Officer	351.49k	N/A	1963
Ms. Michelle Strong	Chief Operations Officer	N/A	N/A	N/A
Ms. Annette L. Heroux	Vice President of Administration	174.9k	N/A	1957
Brian Testa	Chief People Officer	N/A	N/A	N/A
Mr. Bill Keyes	Senior VP of Global Sales Operations	N/A	N/A	N/A
Mr. Vasu Avadhanula	Chief Product Officer	N/A	N/A	N/A
Mr. Peter Graham	Senior VP of North American Sales	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Corporate Governance

iCAD, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 5. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.